Department of Oriental Medicine, College of Oriental Medicine and Institute of Oriental Medicine, Kyung Hee University, Seoul, Republic of Korea.
Pharm Biol. 2012 Oct;50(10):1210-8. doi: 10.3109/13880209.2012.664151. Epub 2012 Aug 2.
Nobiletin is one of the citrus bioflavonoids and can be found in citrus fruits such as lemons, oranges, tangerines, and grapefruits. The most studied properties of nobiletin are its anti-inflammatory and anticancer activities.
The exact mechanisms of how nobiletin inhibits tumor metastasis and invasion are still not fully understood. In this study, we screened various natural compounds to down-modulate the CXC chemokine receptor-4 (CXCR4) and matrix metallopeptidase-9 (MMP-9).
The effect of nobiletin on the constitutive expressions of CXCR4 and MMP-9, MMP-9 enzymatic activity, associated nuclear factor κB (NF-κB) and mitogen-activated protein kinases (MAPKs) activation, and tumor cell invasion in human breast cancer cells was investigated. CXCR4 and MMP-9 expression were evaluated via reverse transcription polymerase chain reaction (RT-PCR) and western blotting. NF-κB activation was also evaluated by electrophoretic mobility shift assay (EMSA). In addition, the antimetastatic effects of nobiletin were determined by gelatin zymography and invasion assay.
Nobiletin down-regulated both the constitutive expressions of CXCR4 and MMP-9 in human breast cancer cells with IC(50) values of 32 and 24 µM, respectively. Nobiletin also suppressed MMP-9 enzymatic activity and tumor cell invasion under noncytotoxic concentrations. Neither proteasome inhibition nor lysosomal stabilization had any effect on the nobiletin-induced decrease in CXCR4 expression. A detailed study of the underlying molecular mechanisms revealed that the regulation of the down-regulation of CXCR4 and MMP-9 were at the transcriptional level, as indicated by the down-regulation of mRNA expression and the suppression of the constitutive NF-κB and MAPKs activation.
Our results indicate, for the first time, that nobiletin is a novel blocker of CXCR4 and MMP-9 expressions and thus has the potential to suppress metastasis of breast cancer.
川陈皮素是一种柑橘类生物类黄酮,可在柠檬、橘子、橘子和葡萄柚等柑橘类水果中找到。川陈皮素研究最多的特性是其抗炎和抗癌活性。
川陈皮素抑制肿瘤转移和侵袭的确切机制尚不完全清楚。在这项研究中,我们筛选了各种天然化合物来下调趋化因子受体 4(CXCR4)和基质金属蛋白酶-9(MMP-9)。
研究了川陈皮素对人乳腺癌细胞中 CXCR4 和 MMP-9 的组成型表达、MMP-9 酶活性、相关核因子κB(NF-κB)和丝裂原活化蛋白激酶(MAPKs)的激活以及肿瘤细胞侵袭的影响。通过逆转录聚合酶链反应(RT-PCR)和蛋白质印迹法评估 CXCR4 和 MMP-9 的表达。通过电泳迁移率变动分析(EMSA)还评估了 NF-κB 的激活。此外,通过明胶酶谱和侵袭试验确定了川陈皮素的抗转移作用。
川陈皮素以 32 和 24 μM 的 IC50 值分别下调人乳腺癌细胞中 CXCR4 和 MMP-9 的组成型表达。川陈皮素在非细胞毒性浓度下也抑制 MMP-9 酶活性和肿瘤细胞侵袭。蛋白酶体抑制或溶酶体稳定化对川陈皮素诱导的 CXCR4 表达降低均无影响。对潜在分子机制的详细研究表明,下调 CXCR4 和 MMP-9 的调节是在转录水平上进行的,这表明 mRNA 表达下调和组成型 NF-κB 和 MAPKs 激活的抑制。
我们的结果首次表明,川陈皮素是 CXCR4 和 MMP-9 表达的新型阻滞剂,因此具有抑制乳腺癌转移的潜力。